Ansana Secures a EUR 1.5 Million Seed Round to Bring Smart Sterilization Technology to Market

We are proud to announce that Ansana, one of NLC’s health-tech ventures, has successfully closed a EUR 1.5 million Seed Round. The round is backed by NLC Health Ventures, Healthliant Ventures, BGO Ventures, and a group of private investors.

This funding will enable Ansana to develop its minimum viable product, achieve ISO 13485 certification, and launch pilot projects in clinical settings. These milestones mark a critical step toward scaling its technology and preparing for commercial rollout, a journey that began at NLC when Ansana was first built through our venture-building model.

Ansana’s solution, SteriWatch, is a state-of-the-art platform that combines a smart medical device with integrated sensors, real-time track-and-trace technology, and advanced data modules. SteriWatch supports quality release, scheduling, inventory optimization, and operating room service management. The system helps guarantee instrument sterility, reduces surgical site infections, and enables digital workflows that improve instrument turnaround while reducing the need for large instrument inventories. By eliminating consumables used in sterilization, SteriWatch also helps decrease the healthcare sector’s carbon footprint – driving both clinical and sustainability benefits.

The investment also builds on Ansana’s strategic partnership with Healthliant Ventures, where SteriWatch will be piloted in its surgical instrument reprocessing workflows.

“Partnering with Ansana underscores our commitment to supply the sterilization departments from Tanner Health System with smart technology that enhances patient safety and operational efficiency,” said Steve West, managing director, Healthliant Ventures. “SteriWatch promises to streamline reprocessing, reduce infection risk for patients, support sustainability and improve surgical workflows across our system.”

“Ansana’s technology tackles a critical challenge in hospitals by ensuring sterile instruments while also driving efficiency and sustainability. This is exactly the type of innovation we want to see reaching patients and the kind of solution we are proud to support through our funds,” said Margarida Lopes at NLC Health Ventures.

“Next to the immediate patient and operational benefits, SteriWatch supports the strategic growth objectives of healthcare systems and hospital groups. This by enabling a network and centralized approach towards surgical instrument reprocessing. Further, it installs the basis for continuous and long-term process improvements,” said Dominique Surinx, CEO and co-founder of Ansana. “The team is so excited to continue our fast development and impact positively patients and healthcare workers globally.”

‍

‍

^{About Ansana
Ansana is one of NLC’s ventures redefining surgical instrument reprocessing through its innovative smart sterilization system, SteriWatch, which integrates sensors and real-time track-and-trace capabilities into containers to guarantee sterility and full traceability throughout the instrument’s lifecycle. Its mission is to improve patient safety and make healthcare more sustainable and affordable. Ansana seeks to become the standard in sterilization process management and control in healthcare and pharmaceuticals. Learn more at ansana.health.}

^{About Healthliant Ventures
Healthliant Ventures is the innovation-focused division of Tanner Health System, created to partner with startups in validating, co-developing, and scaling innovative healthcare technologies. With access to Tanner’s clinical and operational strengths, including five hospitals and one of metro Atlanta’s largest physician groups, Healthliant offers a real-world proving ground that accelerates adoption across health systems. Learn more at healthliant.com.}

^{About Tanner Health System
Tanner Health System is a five-hospital nonprofit health system serving communities across west Georgia and east Alabama. Tanner Medical Group, one of metro Atlanta’s largest multi-specialty physician networks, supports high-quality personalized care powered by advanced technologies and treatment options. Learn more at tanner.org.}

^{About BGO Ventures
BGO Ventures is the corporate venture capital arm of technology company BGO Software. As a healthcare-focused CVC with deep domain expertise in digital health innovation and enterprise software solutions, BGO Ventures combines strategic capital deployment with hands-on technical development support.}

^{About NLC Health Ventures
NLC Health Ventures is Europe’s leading health-tech venture builder, with a portfolio of ventures spanning medical devices, digital health, and biotech. Leveraging its structured venture-building model and extensive global network, NLC helps transform cutting-edge science and engineering into impactful health solutions for patients worldwide. The NLC Health Impact Fund is NLC's latest and largest fund. With a total size of €33.4mn, it invests in a highly diversified portfolio of 60+ groundbreaking NLC ventures. Learn more at nlc.health/funds.}

^‍